Taku Fujimura

Dr. Taku Fujimura

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2016 in Nature Immunology
Verified
Journal Article
Closed access
THTakanori Hidaka
Takanori Hidaka
EOEisaku Ogawa
Eisaku Ogawa
EKEri H Kobayashi
Eri H Kobayashi
TSTakafumi Suzuki
Takafumi Suzuki
RFRyo Funayama
Ryo Funayama
MYMasayuki Yamamoto
Masayuki Yamamoto

1 April 2012 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
TFTaku Fujimura
Taku Fujimura
SRSabine Ring
Sabine Ring
VUViktor Umansky
Viktor Umansky
KMKarsten Mahnke
Karsten Mahnke
AEAlexander H. Enk
Alexander H. Enk

23 January 2018 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
TFTaku Fujimura
Taku Fujimura
YKYumi Kambayashi
Yumi Kambayashi
YFYasuhiro Fujisawa
Yasuhiro Fujisawa
THTakanori Hidaka
Takanori Hidaka
SASetsuya Aiba
Setsuya Aiba
Tumor-associated macrophages (TAMs) and regulatory T cells (Tregs) are significant components of the microenvironment of solid tumors in the majority of cancers. TAMs sequentially develop from monocytes into functional macrophages. In each differentiation stage, TAMs obtain various immunosuppressive functions to maintain the tumor microenvironment (e.g., expression of immune checkpoint molecules, production of Treg-related chemokines and cytokines, production of arginase I). Although the main population of TAMs is immunosuppressive M2 macrophages, TAMs can be modulated into M1-type macrophages in each differential stage, leading to the suppression of tumor growth. Because the administration of certain drugs or stromal factors can stimulate TAMs to produce specific chemokines, leading to the recruitment of various tumor-infiltrating lymphocytes, TAMs can serve as targets for cancer immunotherapy. In this review, we discuss the differentiation, activation, and immunosuppressive function of TAMs, as well as their benefits in cancer immunotherapy.

4 November 2012 in OncoImmunology
Verified
Journal Article
Open access
TFTaku Fujimura
Taku Fujimura
YKYumi Kambayashi
Yumi Kambayashi
SASetsuya Aiba
Setsuya Aiba
Myeloid derived suppressor cells (MDSCa) are a heterogeneous population of cells that promote an immunosuppressive environment in tumor-bearing hosts. Recently, B7-H1 signaling has been reported to...

1 April 2019 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
YFYasuhiro Fujisawa
Yasuhiro Fujisawa
SYShusuke Yoshikawa
Shusuke Yoshikawa
AMAkane Minagawa
Akane Minagawa
TTTatsuya Takenouchi
Tatsuya Takenouchi
KYKenji Yokota
Kenji Yokota
NKNorito Katoh
Norito Katoh
Background: The incidence of melanoma among those of an Asian ethnicity is lower than in Caucasians; few large‐scale Asian studies that include follow‐up data have been reported.Objectives: To investigate the clinical characteristics of Japanese patients with melanoma and to evaluate the prognostic factors.Methods: Detailed patient information was collected from the database of Japanese Melanoma Study Group of the Japanese Skin Cancer Society. The American Joint Committee on Cancer seventh Edition system was used for TNM classification. The Kaplan‐Meier method and Cox proportional hazards model were used to estimate the impact of clinical and histological parameters on disease‐specific survival in patients with invasive melanoma.Results: In total, 4594 patients were included in this analysis. The most common clinical type was acral lentiginous melanoma (40.4%) followed by superficial spreading melanoma (20.5%), nodular melanoma (10.0%), mucosal melanoma (9.5%), and lentigo maligna melanoma (8.1%). The 5‐year disease‐specific survival for each stage was as follows: IA = 98.0%, IB = 93.9%, IIA = 94.8%, IIB = 82.4%, IIC = 71.8%, IIIA = 75.0%, IIIB = 61.3%, IIIC = 41.7%, and IV = 17.7%. Although multivariate analysis showed that clinical classifications were not associated with survival across all stages, acral type was an independent poor prognostic factor in stage IIIA.Conclusions: Our study revealed the characteristics of melanoma in the Japanese population. The 5‐year disease‐specific survival of each stage showed a similar trend to that of Caucasians. While clinical classification was not associated with survival in any stages, acral type was associated with poor survival in stage IIIA. Our result might indicate the aggressiveness of acral type in certain populations.

16 December 2005 in International Immunology
Verified
Journal Article
Open access
PDF file
SCShuming Chen
Shuming Chen
NINaoto Ishii
Naoto Ishii
SIShouji Ine
Shouji Ine
SISyuichi Ikeda
Syuichi Ikeda
TFTaku Fujimura
Taku Fujimura
KSKazuo Sugamura
Kazuo Sugamura
Adult T cell leukemia (ATL) is an aggressive neoplastic disease, in which a quarter of the patients develop opportunistic infections due to cellular immunodeficiency. However, the underlying mechanism responsible for the immunosuppression has remained unclear. Recent studies have demonstrated that the leukemia cells from a subset of patients with ATL express Foxp3, a specific marker for CD25+CD4+ regulatory T (Treg) cells, which regulate the immune response by suppressing CD4+ T cell functions. However, whether there is a functional resemblance between ATL cells that have Foxp3 expression and Treg cells is still unknown. In this report, we confirmed the high expression of Foxp3 in leukemia cells from 5 of 12 ATL patients and demonstrated that ATL cells from 3 patients suppressed the proliferation of CD4+ T cells. Similarly, one of six HTLV-I-infected cell lines showed both high Foxp3 expression and suppressive activity. Like Treg cells, the suppression induced by the ATL cells from two patients and the HTLV-infected cell line appeared to be mediated by a cell–cell contact-dependent mechanism. Nevertheless, among the ATL cells that strongly expressed Foxp3, those from two of the five patients showed no apparent suppressive activity. Furthermore, retroviral transfection of Foxp3 did not confer any suppressive function on low Foxp3-expressing HTLV-I-infected cell lines. These results indicate that Foxp3 may be essential but is not sufficient for the Treg-cell-like suppressive activity of ATL cells and HTLV-I-infected cell lines.